查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球兽用抗感染药物市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按物种类型、按药物类别、按管理模式、按分销管道、按地区
市场调查报告书
商品编码
1394132

全球兽用抗感染药物市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按物种类型、按药物类别、按管理模式、按分销管道、按地区

Veterinary Anti-Infectives Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 232 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球兽用抗感染药市场正在发生重大变化，北美成为利润最高的地区。 这一趋势的推动因素包括宠物拥有量的增加、动物饲养需求的增加以及对食品安全的日益担忧。 此外，宠物保险的采用率正在上升，美国的参与率每年增长 10%，令人震惊。

北美市场以美国为主导，预计在预测期内将占据超过75%的份额。 加拿大也表现出强劲的成长，预计复合年增长率为 4%。 北美市场占有率预计将超过15亿美元。

另一方面，亚太地区正在经历快速成长，主要公司专注于促进小动物照护、蓬勃发展的畜牧业以及印度的销售合作伙伴关係。

全球兽用抗感染药物市场以抗菌药物为主导，紧随其后的是抗病毒药物。 在抗菌药物类别中，青霉素类、头孢菌素类和四环素类成长速度较高。 抗病毒药物预计将成为按药物类别排名第二的最受青睐的细分市场，在评估期间市场吸引力指数为 1.2。

生物製剂和特殊药物为全球兽用抗感染药物市场的主要参与者提供了重大机会。 历史上较低的研发回报正在推动新产品开发 (NPD) 的需求。 研究和开发，特别是生物製品和专业医学的创新，提供了许多机会。 此外，治疗药物的可负担性不断提高以及消费者对宠物护理和牲畜的意识增强也提供了强劲的成长前景，特别是对于新进业者而言。

本报告调查了全球兽用抗感染药物市场，并按品种类型、药物类别、给药方式、分销渠道、区域趋势和市场参与者提供了市场概况。它提供了有关公司竞争趋势的信息。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第三章2018-2031年全球兽用抗感染药物市场前景

  • 2018-2031 年全球兽用抗感染药物市场前景（按物种类型、价值（百万美元））
  • 2018-2031 年全球兽用抗感染药物市场前景（依药物类别、价值（百万美元））
  • 2018-2031 年全球兽用抗感染药物市场前景（以给药方式划分）、价值（百万美元）
  • 2018-2031 年全球兽用抗感染药物市场前景（按分销管道）、价值（百万美元）
  • 2018-2031 年全球兽用抗感染药物市场前景（按地区、价值（百万美元））

第四章2018-2031年北美兽用抗感染药物市场前景

第五章欧洲兽用抗感染药物市场前景，2018-2031

第六章2018-2031年亚太地区兽用抗感染药物市场前景

第七章2018-2031年拉丁美洲兽用抗感染药物市场展望

第8章2018-2031年中东及非洲兽用抗感染药物市场前景

第九章竞争态势

  • 依给药模式和药物类别划分的热图
  • 按製造商和药品类别划分的热图
  • 2023 年公司市占率分析
  • 竞争力仪表板
  • 公司简介
    • Bayer AG
    • Cipla Limited
    • Dechra Pharmaceuticals PLC
    • Eli Lilly and Company (Elanco Animal Health)
    • Heska Corp (Diamond Animal Health)
    • Merck & Co., Inc. (Merck Animal Health)
    • Neogen Corporation
    • Phibro Animal Health Corporation
    • Sanofi (Merial Animal Health)
    • Vetoquinol S.A.
    • Virbac S.A.
    • Zoetis, Inc.
    • Boehringer Ingelheim GmbH
    • Ceva Sante Animale
    • Indian Immunologicals Limited
    • Intas Pharmaceuticals Limited
    • Norbrook Laboratories Limited
    • Zydus Animal Health Limited
    • Ashish Life Science Private Limited
    • Oceanic Pharmachem Private Limited.

第 10 章附录

简介目录

The global veterinary anti-infectives market is witnessing a significant shift in dynamics, with North America emerging as the most lucrative region. This trend can be attributed to the increasing pet ownership, a rising demand for enhanced animal nutrition, and a heightened focus on food safety. Furthermore, the adoption of pet insurance is on the rise, with enrollment in the United States growing at an impressive 10% per year.

North America: A Lucrative Hub The United States market leads the way in North America, expected to represent over 75% share during the forecast period. Canada is also set to exhibit robust growth with a projected CAGR of 4%. North America is expected to reach a market value share of more than US$ 1500 Mn.

Asia Pacific: Rapid Expansion Meanwhile, the Asia Pacific (APAC) region is experiencing rapid growth driven by the promotion of small animal care, a thriving livestock segment, and key players focusing on distribution partnerships in India.

Segment Insights: The antimicrobial agents segment leads the global veterinary anti-infectives market, closely followed by antiviral agents. Within the antimicrobial agents category, Penicillins, Cephalosporins, and Tetracyclines account for a higher growth rate. The antiviral agents segment is anticipated to be the second most lucrative segment by drug class, showcasing a market attractiveness index of 1.2 during the assessment period.

Unveiling Opportunities Biologics and specialty care present significant opportunities for key players in the global veterinary anti-infectives market. Past low returns on research and development have spurred a demand for New Product Development (NPD). Innovation in research and development, particularly in biologics and specialty care, offers a plethora of opportunities. Moreover, the increasing affordability of therapeutics and growing consumer awareness about pet care and livestock contribute to significant growth prospects, especially for new market entrants.

Comprehensive Market Segmentation The veterinary anti-infectives market research report provides a comprehensive segmentation based on several attributes:

1. By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific (APAC)
  • Middle East and Africa (MEA)

2. By Species Type:

  • Livestock Animals
  • Companion Animals

3. By Drug Class:

  • Antimicrobial Agents
  • Tetracyclines
  • Penicillins
  • Cephalosporins
  • Macrolides
  • Quinolones
  • Others
  • Antiviral Agents
  • Antifungal Agents
  • Antiparasitic Agents
  • Others

4. By Mode of Administration:

  • Oral
  • Parenteral
  • Topical

5. By Distribution Channel:

  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies
  • Others

These segmentation attributes enable a deeper understanding of market dynamics, regional variations, sub-segment analysis, and more.

Table of Contents

1. Executive Summary

  • 1.1. Global Veterinary Anti-Infectives Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 3.1. Global Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Livestock Animals
      • 3.1.1.2. Companion Animals
  • 3.2. Global Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Antimicrobial Agents
        • 3.2.1.1.1. Tetracyclines
        • 3.2.1.1.2. Penicillins
        • 3.2.1.1.3. Cephalosporins
        • 3.2.1.1.4. Macrolides
        • 3.2.1.1.5. Quinolones
        • 3.2.1.1.6. Others
      • 3.2.1.2. Antiviral Agents
      • 3.2.1.3. Antifungal Agents
      • 3.2.1.4. Antiparasitic Agents
      • 3.2.1.5. Others
  • 3.3. Global Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Oral
      • 3.3.1.2. Parenteral
      • 3.3.1.3. Topical
  • 3.4. Global Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Veterinary Hospitals
      • 3.4.1.2. Veterinary Clinics
      • 3.4.1.3. Pharmacies
      • 3.4.1.4. Others
  • 3.5. Global Veterinary Anti-Infectives Market Outlook, by Region, Value (US$ Mn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 4.1. North America Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Livestock Animals
      • 4.1.1.2. Companion Animals
  • 4.2. North America Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Antimicrobial Agents
        • 4.2.1.1.1. Tetracyclines
        • 4.2.1.1.2. Penicillins
        • 4.2.1.1.3. Cephalosporins
        • 4.2.1.1.4. Macrolides
        • 4.2.1.1.5. Quinolones
        • 4.2.1.1.6. Others
      • 4.2.1.2. Antiviral Agents
      • 4.2.1.3. Antifungal Agents
      • 4.2.1.4. Antiparasitic Agents
      • 4.2.1.5. Others
  • 4.3. North America Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Oral
      • 4.3.1.2. Parenteral
      • 4.3.1.3. Topical
  • 4.4. North America Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Veterinary Hospitals
      • 4.4.1.2. Veterinary Clinics
      • 4.4.1.3. Pharmacies
      • 4.4.1.4. Others
  • 4.5. North America Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.2. U.S. Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 4.5.1.3. U.S. Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 4.5.1.4. U.S. Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 4.5.1.5. Canada Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 4.5.1.6. Canada Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 4.5.1.7. Canada Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 4.5.1.8. Canada Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 5.1. Europe Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Livestock Animals
      • 5.1.1.2. Companion Animals
  • 5.2. Europe Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Antimicrobial Agents
        • 5.2.1.1.1. Tetracyclines
        • 5.2.1.1.2. Penicillins
        • 5.2.1.1.3. Cephalosporins
        • 5.2.1.1.4. Macrolides
        • 5.2.1.1.5. Quinolones
        • 5.2.1.1.6. Others
      • 5.2.1.2. Antiviral Agents
      • 5.2.1.3. Antifungal Agents
      • 5.2.1.4. Antiparasitic Agents
      • 5.2.1.5. Others
  • 5.3. Europe Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Oral
      • 5.3.1.2. Parenteral
      • 5.3.1.3. Topical
  • 5.4. Europe Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Veterinary Hospitals
      • 5.4.1.2. Veterinary Clinics
      • 5.4.1.3. Pharmacies
      • 5.4.1.4. Others
  • 5.5. Europe Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.2. Germany Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.3. Germany Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.4. Germany Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.5. U.K. Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.6. U.K. Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.7. U.K. Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.8. U.K. Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.9. France Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.10. France Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.11. France Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.12. France Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.13. Italy Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.14. Italy Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.15. Italy Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.16. Italy Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.17. Turkey Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.18. Turkey Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.19. Turkey Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.20. Turkey Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.21. Russia Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.22. Russia Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.23. Russia Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.24. Russia Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Livestock Animals
      • 6.1.1.2. Companion Animals
  • 6.2. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Antimicrobial Agents
        • 6.2.1.1.1. Tetracyclines
        • 6.2.1.1.2. Penicillins
        • 6.2.1.1.3. Cephalosporins
        • 6.2.1.1.4. Macrolides
        • 6.2.1.1.5. Quinolones
        • 6.2.1.1.6. Others
      • 6.2.1.2. Antiviral Agents
      • 6.2.1.3. Antifungal Agents
      • 6.2.1.4. Antiparasitic Agents
      • 6.2.1.5. Others
  • 6.3. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Oral
      • 6.3.1.2. Parenteral
      • 6.3.1.3. Topical
  • 6.4. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Veterinary Hospitals
      • 6.4.1.2. Veterinary Clinics
      • 6.4.1.3. Pharmacies
      • 6.4.1.4. Others
  • 6.5. Asia Pacific Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.2. China Veterinary Anti-Infectives Market Sample Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.3. China Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.4. China Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.5. Japan Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.6. Japan Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.7. Japan Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.8. Japan Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.9. South Korea Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.10. South Korea Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.11. South Korea Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.12. South Korea Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.13. India Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.14. India Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.15. India Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.16. India Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 7.1. Latin America Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Livestock Animals
      • 7.1.1.2. Companion Animals
  • 7.2. Latin America Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Antimicrobial Agents
        • 7.2.1.1.1. Tetracyclines
        • 7.2.1.1.2. Penicillins
        • 7.2.1.1.3. Cephalosporins
        • 7.2.1.1.4. Macrolides
        • 7.2.1.1.5. Quinolones
        • 7.2.1.1.6. Others
      • 7.2.1.2. Antiviral Agents
      • 7.2.1.3. Antifungal Agents
      • 7.2.1.4. Antiparasitic Agents
      • 7.2.1.5. Others
  • 7.3. Latin America Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Oral
      • 7.3.1.2. Parenteral
      • 7.3.1.3. Topical
  • 7.4. Latin America Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Veterinary Hospitals
      • 7.4.1.2. Veterinary Clinics
      • 7.4.1.3. Pharmacies
      • 7.4.1.4. Others
  • 7.5. Latin America Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.2. Brazil Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.3. Brazil Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.4. Brazil Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 7.5.1.5. Mexico Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.6. Mexico Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.7. Mexico Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.8. Mexico Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 7.5.1.9. Argentina Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.10. Argentina Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.11. Argentina Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.12. Argentina Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Veterinary Anti-Infectives Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Species Type, Value (US$ Mn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Livestock Animals
      • 8.1.1.2. Companion Animals
  • 8.2. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Drug Class, Value (US$ Mn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Antimicrobial Agents
        • 8.2.1.1.1. Tetracyclines
        • 8.2.1.1.2. Penicillins
        • 8.2.1.1.3. Cephalosporins
        • 8.2.1.1.4. Macrolides
        • 8.2.1.1.5. Quinolones
        • 8.2.1.1.6. Others
      • 8.2.1.2. Antiviral Agents
      • 8.2.1.3. Antifungal Agents
      • 8.2.1.4. Antiparasitic Agents
      • 8.2.1.5. Others
  • 8.3. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Mode of Administration, Value (US$ Mn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Oral
      • 8.3.1.2. Parenteral
      • 8.3.1.3. Topical
  • 8.4. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Veterinary Hospitals
      • 8.4.1.2. Veterinary Clinics
      • 8.4.1.3. Pharmacies
      • 8.4.1.4. Others
  • 8.5. Middle East & Africa Veterinary Anti-Infectives Market Outlook, by Country, Value (US$ Mn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.2. GCC Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.3. GCC Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.4. GCC Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.5. South Africa Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.6. South Africa Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.7. South Africa Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.8. South Africa Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.9. Egypt Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.10. Egypt Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.11. Egypt Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.12. Egypt Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.13. Nigeria Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.14. Nigeria Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.15. Nigeria Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.16. Nigeria Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Species Type, Value (US$ Mn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Drug Class, Value (US$ Mn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Mode of Administration, Value (US$ Mn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Veterinary Anti-Infectives Market by Distribution Channel, Value (US$ Mn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. by Mode of Administration vs by Drug Class Heatmap
  • 9.2. Manufacturer vs by Drug Class Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Bayer AG
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Cipla Limited
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Dechra Pharmaceuticals PLC
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Eli Lilly and Company (Elanco Animal Health)
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Heska Corp (Diamond Animal Health)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Merck & Co., Inc. (Merck Animal Health)
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Neogen Corporation
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Phibro Animal Health Corporation
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Sanofi (Merial Animal Health)
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Vetoquinol S.A.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Virbac S.A.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Zoetis, Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. Boehringer Ingelheim GmbH
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Ceva Sante Animale
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. Indian Immunologicals Limited
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development
    • 9.5.16. Intas Pharmaceuticals Limited
      • 9.5.16.1. Company Overview
      • 9.5.16.2. Product Portfolio
      • 9.5.16.3. Financial Overview
      • 9.5.16.4. Business Strategies and Development
    • 9.5.17. Norbrook Laboratories Limited
      • 9.5.17.1. Company Overview
      • 9.5.17.2. Product Portfolio
      • 9.5.17.3. Financial Overview
      • 9.5.17.4. Business Strategies and Development
    • 9.5.18. Zydus Animal Health Limited
      • 9.5.18.1. Company Overview
      • 9.5.18.2. Product Portfolio
      • 9.5.18.3. Financial Overview
      • 9.5.18.4. Business Strategies and Development
    • 9.5.19. Ashish Life Science Private Limited
      • 9.5.19.1. Company Overview
      • 9.5.19.2. Product Portfolio
      • 9.5.19.3. Financial Overview
      • 9.5.19.4. Business Strategies and Development
    • 9.5.20. Oceanic Pharmachem Private Limited.
      • 9.5.20.1. Company Overview
      • 9.5.20.2. Product Portfolio
      • 9.5.20.3. Financial Overview
      • 9.5.20.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations